BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30570551)

  • 1. PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 Cases.
    Puls F; Pillay N; Fagman H; Palin-Masreliez A; Amary F; Hansson M; Kindblom LG; McCulloch TA; Meligonis G; Muc R; Rissler P; Sumathi VP; Tirabosco R; Hofvander J; Magnusson L; Nilsson J; Flanagan AM; Mertens F
    Am J Surg Pathol; 2019 Apr; 43(4):504-513. PubMed ID: 30570551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
    Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
    Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases.
    Anderson WJ; Mertens F; Mariño-Enríquez A; Hornick JL; Fletcher CDM
    Am J Surg Pathol; 2022 Oct; 46(10):1329-1339. PubMed ID: 35713642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity.
    Zhao M; Yin X; He H; Fan Y; Ru G; Meng X
    Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
    Hofvander J; Puls F; Pillay N; Steele CD; Flanagan AM; Magnusson L; Nilsson J; Mertens F
    J Pathol; 2019 Dec; 249(4):425-434. PubMed ID: 31313299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.
    Puls F; Carter JM; Pillay N; McCulloch TA; Sumathi VP; Rissler P; Fagman H; Hansson M; Amary F; Tirabosco R; Magnusson L; Nilsson J; Flanagan AM; Folpe AL; Mertens F
    Mod Pathol; 2022 Jun; 35(6):767-776. PubMed ID: 34969957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical positive regulatory domain member 10 expression in soft tissue sarcomas.
    Mistik O; Sayar H
    Pol J Pathol; 2022; 73(3):223-232. PubMed ID: 36734437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma.
    Hofvander J; Tayebwa J; Nilsson J; Magnusson L; Brosjö O; Larsson O; Vult von Steyern F; Mandahl N; Fletcher CD; Mertens F
    Clin Cancer Res; 2015 Feb; 21(4):864-9. PubMed ID: 25516889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial CD34 fibroblastic tumors and PRDM10-rearranged soft tissue neoplasm: An evolving diagnosis.
    Johnson C; Parsa L; Gibbs J; Sligh J
    J Cutan Pathol; 2024 Jan; 51(1):11-14. PubMed ID: 37150806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial CD34 Positive Fibroblastic Tumour with Myxoid Stroma.
    Bruce-Brand C; Conradie W; Schneider JW
    Int J Surg Pathol; 2023 Aug; 31(5):751-754. PubMed ID: 36221951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma.
    Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U
    Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
    Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
    Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I; Godschachner TM; Bergovec M; Igrec J; Till H; Lackner H; Scheipl S; Kashofer K; Brodowicz T; Leithner A; Szkandera J; Liegl-Atzwanger B
    Mod Pathol; 2021 Feb; 34(2):396-407. PubMed ID: 32860002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics.
    Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T
    Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.
    Carter JM; Sukov WR; Montgomery E; Goldblum JR; Billings SD; Fritchie KJ; Folpe AL
    Am J Surg Pathol; 2014 Sep; 38(9):1182-992. PubMed ID: 24705316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
    Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
    Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
    Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
    Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
    Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas.
    Kreiger PA; Judkins AR; Russo PA; Biegel JA; Lestini BJ; Assanasen C; Pawel BR
    Mod Pathol; 2009 Jan; 22(1):142-50. PubMed ID: 18997735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.